Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Influenza

Free Subscription 02.10.2023 2 Am J Med 5 BMJ 4 J Infect Dis 1 J Virol 5 JAMA 4 Lancet 1 MMWR Morb Mortal Wkly Rep 1 PLoS Comput Biol 2 PLoS Med 19 PLoS One 17 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Med

1. GRAHAM DJ, Izurieta HS, Zhang D, Avagyan A, et al
   Risk of Severe COVID-19 in Prevalent Users of Alpha-1 Adrenergic Receptor Antagonists: A National Case-Control Study of Medicare Beneficiaries.
   Am J Med. 2023;136:1018-1025.
   PubMed         Abstract available
   
   
2. BRYAN NS, Molnar J, Somberg J
   The Efficacy of Nitric Oxide-Generating Lozenges on Outcome in Newly Diagnosed COVID-19 Patients of African American and Hispanic Origin.
   Am J Med. 2023;136:1035-1040.
   PubMed         Abstract available
   
   

   
   BMJ

3. THOBEGA K
   How Botswana discovered the omicron variant.
   BMJ. 2023;382:p1653.
   PubMed        
   
   
4. 
   Efficacy and safety of an inactivated virus-particle vaccine for SARS-CoV-2, BIV1-CovIran: randomised, placebo controlled, double blind, multicentre, phase 3 clinical trial.
   BMJ. 2023;382:p2193.
   PubMed        
   
   
5. MCCARTNEY PR
   Covid-19 boosters: improving patient information leaflets.
   BMJ. 2023;382:p2100.
   PubMed        
   
   
6. KMIETOWICZ Z
   BMA calls for investigation into debacle over covid and flu vaccinations.
   BMJ. 2023;382:p2184.
   PubMed        
   
   
7. MOHRAZ M, Vahdat K, Ghamari SH, Abbasi-Kangevari M, et al
   Efficacy and safety of an inactivated virus-particle vaccine for SARS-CoV-2, BIV1-CovIran: randomised, placebo controlled, double blind, multicentre, phase 3 clinical trial.
   BMJ. 2023;382:e070464.
   PubMed         Abstract available
   
   

   
   J Infect Dis

8. BASU THAKUR P, Mrotz VJ, Maines TR, Belser JA, et al
   Ferrets as a mammalian model to study influenza virus-bacteria interactions.
   J Infect Dis. 2023 Sep 22:jiad408. doi: 10.1093.
   PubMed         Abstract available
   
   
9. HAYDEN FG, Lenk RP, Epstein C, Kang LL, et al
   Oral Favipiravir Exposure and Pharmacodynamic Effects in Outpatient Adults with Acute Influenza.
   J Infect Dis. 2023 Sep 22:jiad409. doi: 10.1093.
   PubMed         Abstract available
   
   
10. HOWA AC, Zhu Y, Wyatt D, Markus T, et al
    Estimating the Burden of Influenza Hospitalizations Across Multiple Seasons Using Capture-Recapture.
    J Infect Dis. 2023 Sep 28:jiad417. doi: 10.1093.
    PubMed         Abstract available
    
    
11. ANDREEV K, Jones JC, Seiler P, Kandeil A, et al
    Antiviral Susceptibility of Highly Pathogenic Avian Influenza A(H5N1) Viruses Circulating Globally in 2022-2023.
    J Infect Dis. 2023 Sep 28:jiad418. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Virol

12. WALLACE LE, de Vries E, van Kuppeveld FJM, de Haan CAM, et al
    Neuraminidase-dependent entry of influenza A virus is determined by hemagglutinin receptor-binding specificity.
    J Virol. 2023 Sep 27:e0060223. doi: 10.1128/jvi.00602.
    PubMed         Abstract available
    
    

    
    JAMA

13. LUGAR M, Eugster A, Achenbach P, von dem Berge T, et al
    SARS-CoV-2 Infection and Development of Islet Autoimmunity in Early Childhood.
    JAMA. 2023 Sep 8. doi: 10.1001/jama.2023.16348.
    PubMed         Abstract available
    
    
14. HARRIS E
    High Blood Pressure More Likely After COVID-19 Than Flu.
    JAMA. 2023 Sep 6. doi: 10.1001/jama.2023.16676.
    PubMed        
    
    
15. HARRIS E
    HHS To Invest $1.4 Billion in New COVID-19 Vaccines, Therapies.
    JAMA. 2023 Sep 6. doi: 10.1001/jama.2023.16678.
    PubMed        
    
    
16. HARRIS E
    Some People Still Have Long COVID Symptoms After 2 Years.
    JAMA. 2023;330:1127.
    PubMed        
    
    
17. HARRIS E
    FDA Approves Maternal RSV Vaccine.
    JAMA. 2023 Aug 30. doi: 10.1001/jama.2023.16106.
    PubMed        
    
    

    
    Lancet

18. MASSUDA A, Dall'Alba R, Chioro A, Temporao JG, et al
    Bolsonaro's Ministry of Health's response to COVID-19 and other health challenges - Authors' reply.
    Lancet. 2023;402:1041-1042.
    PubMed        
    
    
19. PARENTE RCM, Queiroga M
    Bolsonaro's Ministry of Health's response to COVID-19 and other health challenges.
    Lancet. 2023;402:1040-1041.
    PubMed        
    
    
20. ZHANG H
    COVID-19 and Chinese nurses' mental health.
    Lancet. 2023;402:1039-1040.
    PubMed        
    
    
21. KUNG S, Hills T, Kearns N, Beasley R, et al
    New Zealand's COVID-19 elimination strategy and mortality patterns.
    Lancet. 2023 Aug 24:S0140-6736(23)01368-5. doi: 10.1016/S0140-6736(23)01368.
    PubMed        
    
    

    
    MMWR Morb Mortal Wkly Rep

22. RAZZAGHI H, Kahn KE, Calhoun K, Garacci E, et al
    Influenza, Tdap, and COVID-19 Vaccination Coverage and Hesitancy Among Pregnant Women - United States, April 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:1065-1071.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

23. MUNDAY JD, Abbott S, Meakin S, Funk S, et al
    Evaluating the use of social contact data to produce age-specific short-term forecasts of SARS-CoV-2 incidence in England.
    PLoS Comput Biol. 2023;19:e1011453.
    PubMed         Abstract available
    
    

    
    PLoS Med

24. KUCHARSKI AJ, Chung K, Aubry M, Teiti I, et al
    Real-time surveillance of international SARS-CoV-2 prevalence using systematic traveller arrival screening: An observational study.
    PLoS Med. 2023;20:e1004283.
    PubMed         Abstract available
    
    
25. WATKINSON RE, Williams R, Gillibrand S, Munford L, et al
    Evaluating socioeconomic inequalities in influenza vaccine uptake during the COVID-19 pandemic: A cohort study in Greater Manchester, England.
    PLoS Med. 2023;20:e1004289.
    PubMed         Abstract available
    
    

    
    PLoS One

26. LAO T, Avalos I, Rodriguez EM, Zamora Y, et al
    Production and characterization of a chimeric antigen, based on nucleocapsid of SARS-CoV-2 fused to the extracellular domain of human CD154 in HEK-293 cells as a vaccine candidate against COVID-19.
    PLoS One. 2023;18:e0288006.
    PubMed         Abstract available
    
    
27. HOHL CM, Cragg A, Purssel E, McAlister FA, et al
    Comparing methods to classify admitted patients with SARS-CoV-2 as admitted for COVID-19 versus with incidental SARS-CoV-2: A cohort study.
    PLoS One. 2023;18:e0291580.
    PubMed         Abstract available
    
    
28. GREEN C, Beaney T, Salman D, Robb C, et al
    The impacts of social restrictions during the COVID-19 pandemic on the physical activity levels of over 50-year olds: The CHARIOT COVID-19 Rapid Response (CCRR) cohort study.
    PLoS One. 2023;18:e0290064.
    PubMed         Abstract available
    
    
29. SHAH AD, Subramanian A, Lewis J, Dhalla S, et al
    Long Covid symptoms and diagnosis in primary care: A cohort study using structured and unstructured data in The Health Improvement Network primary care database.
    PLoS One. 2023;18:e0290583.
    PubMed         Abstract available
    
    
30. BRADY C, Shackleton E, Fenton C, Loughran O, et al
    Worsening of mental health outcomes in nursing home staff during the COVID-19 pandemic in Ireland.
    PLoS One. 2023;18:e0291988.
    PubMed         Abstract available
    
    
31. BURHAN E, Liu K, Marwali EM, Huth S, et al
    Characteristics and outcomes of patients with severe COVID-19 in Indonesia: Lessons from the first wave.
    PLoS One. 2023;18:e0290964.
    PubMed         Abstract available
    
    
32. BINGHAM J, Tempia S, Moultrie H, Viboud C, et al
    Estimating the time-varying reproduction number for COVID-19 in South Africa during the first four waves using multiple measures of incidence for public and private sectors across four waves.
    PLoS One. 2023;18:e0287026.
    PubMed         Abstract available
    
    
33. DAINTY KN, Seaton MB, Hall JN, Mondoux S, et al
    "It saved me from the emergency department": A qualitative study of patient experience of virtual urgent care in Ontario.
    PLoS One. 2023;18:e0285468.
    PubMed         Abstract available
    
    
34. CELINO SDM, Albuquerque Filho NJB, Gomes MDNC, Costa GMC, et al
    Evaluation of primary health care by users during the COVID-19 pandemic: A cross-sectional study.
    PLoS One. 2023;18:e0292039.
    PubMed         Abstract available
    
    
35. OCRAN T, Barfi KA, Kodua-Ntim K, Kwafoa PNY, et al
    Leveraging social media in digital scholarship: Perspective from developing country students.
    PLoS One. 2023;18:e0291334.
    PubMed         Abstract available
    
    
36. FAN Y, Liu M, Sun G
    An interpretable machine learning framework for diagnosis and prognosis of COVID-19.
    PLoS One. 2023;18:e0291961.
    PubMed         Abstract available
    
    
37. HALAMICEK R, Wiesmann C, Kroner R, Eber M, et al
    Influence of different treatment conditions on the filtration performance of conventional electret melt blown non-woven and novel nano FFP2 masks.
    PLoS One. 2023;18:e0291679.
    PubMed         Abstract available
    
    
38. GEBREMESKEL AT, Udenigwe O, Etowa J, Yaya S, et al
    Unpacking the challenges of fragmentation in community-based maternal newborn and child health and health system in rural Ethiopia: A qualitative study.
    PLoS One. 2023;18:e0291696.
    PubMed         Abstract available
    
    
39. NAI ZL, Tan WS, Tov W
    Acceptance of communication technology, emotional support and subjective well-being for Chinese older adults living alone during COVID-19: A moderated mediation model.
    PLoS One. 2023;18:e0291806.
    PubMed         Abstract available
    
    
40. PARAMASIVAN K, Prakash A, Gupta S, Phukan B, et al
    Resilience of hospital and allied infrastructure during pandemic and post pandemic periods for maternal health care of pregnant women and infants in Tamil Nadu, India - A counterfactual analysis.
    PLoS One. 2023;18:e0291749.
    PubMed         Abstract available
    
    
41. SHEN K, Kejriwal M
    Quantifying COVID-19 policy impacts on subjective well-being during the early phase of the pandemic: A cross-sectional analysis of United States survey data from March to August 2020.
    PLoS One. 2023;18:e0291494.
    PubMed         Abstract available
    
    
42. PYO J, Park EJ, Ock M, Lee W, et al
    How has COVID-19 affected the work environment of delivery workers?: An interpretative phenomenological analysis.
    PLoS One. 2023;18:e0290403.
    PubMed         Abstract available
    
    
43. SHEK DTL, Wong T, Li X, Yu L, et al
    Use of instructional videos in leadership education in higher education under COVID-19: A qualitative study.
    PLoS One. 2023;18:e0291861.
    PubMed         Abstract available
    
    
44. DICKOW J, Gunawardene MA, Willems S, Feldhege J, et al
    Higher in-hospital mortality in SARS-CoV-2 omicron variant infection compared to influenza infection-Insights from the CORONA Germany study.
    PLoS One. 2023;18:e0292017.
    PubMed         Abstract available
    
    

    
    Vaccine

45. CASSARINO N, Ahnger-Pier KK, Wurcel A
    Trends in COVID-19 and influenza vaccine ordering and distribution in Massachusetts jails.
    Vaccine. 2023 Sep 25:S0264-410X(23)01115-5. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    
46. GOLOVKINA MI, Ertz SC, Lechnir SS, Hayney MS, et al
    Providing influenza vaccines at endoscopy visits increases influenza vaccine uptake.
    Vaccine. 2023 Sep 23:S0264-410X(23)01108-8. doi: 10.1016/j.vaccine.2023.
    PubMed        
    
    
47. HOMAIRA N, He WQ, McRae J, Macartney K, et al
    Coverage and predictors of influenza and pertussis vaccination during pregnancy: a whole of population-based study.
    Vaccine. 2023 Sep 21:S0264-410X(23)01062-9. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    
48. WILLIS DE, Moore R, Andersen JA, Li J, et al
    Correlates of COVID-19 vaccine coverage in Arkansas: Results from a weighted random sample survey.
    Vaccine. 2023 Sep 1:S0264-410X(23)01039-3. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    
49. PORRAS-RAMIREZ A, Sanchez-Paris R, Lopez-Devia W, Moreno-Perilla Z, et al
    Confirmed cases of COVID-19 after vaccination against COVID in health personnel in Bogota, Colombia.
    Vaccine. 2023 Sep 1:S0264-410X(23)00924-6. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    
50. GRILLS LA, Wagner AL
    The impact of the COVID-19 pandemic on parental vaccine hesitancy: A cross-sectional survey.
    Vaccine. 2023 Aug 31:S0264-410X(23)00977-5. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    
51. DUDLEY HM, O'Mara M, Auma A, Gong J, et al
    Rheumatoid arthritis and older age are associated with lower humoral and cellular immune response to primary series COVID-19 mRNA vaccine.
    Vaccine. 2023 Aug 31:S0264-410X(23)00965-9. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    
52. REGAN AK, Fell DB, Wise LA, Vazquez-Benitez G, et al
    Challenges & opportunities for the epidemiological evaluation of the effects of COVID-19 vaccination on reproduction and pregnancy.
    Vaccine. 2023 Aug 31:S0264-410X(23)00964-7. doi: 10.1016/j.vaccine.2023.
    PubMed        
    
    
53. RAISER F, Davis M, Adelglass J, Cai MR, et al
    Immunogenicity and safety of NVX-CoV2373 as a booster: A phase 3 randomized clinical trial in adults.
    Vaccine. 2023;41:5965-5973.
    PubMed         Abstract available
    
    
54. HAO F, Shao W
    Social network, political climate, income inequality, and Americans uptake of monovalent COVID-19 booster.
    Vaccine. 2023;41:6077-6082.
    PubMed         Abstract available
    
    
55. PHIRIYASART F, Aimyong N, Jirapongsuwan A, Roseh N, et al
    COVID-19 vaccine hesitancy among older adult Thai Muslim people: A case-control study.
    Vaccine. 2023 Aug 27:S0264-410X(23)00994-5. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    
56. YANG J, Li B, Yang D, Wu J, et al
    The immunogenicity of Alum+CpG adjuvant SARS-CoV-2 inactivated vaccine in mice.
    Vaccine. 2023 Aug 26:S0264-410X(23)01017-4. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    
57. JANSSEN ERC, van Montfoort AZ, Hollman F, Lambers Heerspink FO, et al
    The prevalence and clinical course of shoulder injury related to vaccine administration (SIRVA) after COVID-19 vaccines in Dutch hospital workers.
    Vaccine. 2023 Aug 25:S0264-410X(23)00975-1. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    
58. CHIBA S, Halfmann PJ, Iida S, Hirata Y, et al
    Recombinant spike protein vaccines coupled with adjuvants that have different modes of action induce protective immunity against SARS-CoV-2.
    Vaccine. 2023 Aug 25:S0264-410X(23)01008-3. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    
59. CHEN IR, Wang GJ, Hsueh PR, Chou CH, et al
    Immune responses and safety of COVID-19 vaccination in atypical hemolytic uremic syndrome patients in Taiwan.
    Vaccine. 2023 Aug 25:S0264-410X(23)00952-0. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    
60. DENG L, Tapper K, Thosar D, Goeman E, et al
    Use of adrenaline to manage suspected anaphylaxis following COVID-19 vaccination: An Australian retrospective cohort study.
    Vaccine. 2023 Aug 24:S0264-410X(23)00956-8. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    
61. GOULD S, Wrzesinski C, Stebbings R, Segal L, et al
    Report from an ICT 2022 workshop on toxicology for Covid19 vaccines: Industry, regulatory and CRO perspectives.
    Vaccine. 2023 Aug 24:S0264-410X(23)00972-6. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: